ArticleVirchows Archiv : an international journal of pathology2025
Myeloperoxidase-positive mononuclear cells predominate over CD3-positive T-lymphocytes in the epidermis of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening mucocutaneous conditions traditionally regarded as severe T cell-mediated hypersensitivity reactions. However, recent evidence has highlighted the potential role of myeloperoxidase (MPO), primarily produced by neutrophils, in the pathogenesis of SJS/TEN. Here, we examined the expression of MPO in skin biopsy specimens from patients with SJS/TEN (n = 15) to evaluate its diagnostic utility, comparing the findings with those from patients with erythema multiforme (EM) (n = 8) and graft-versus-host disease (GVHD) (n = 10). MPO-positive mononuclear cells were present in all SJS/TEN cases, often outnumbering CD3-positive T cells (86.7%). A significantly higher number of cases with an MPO/CD3 ratio greater than 1 was observed in patients with SJS/TEN compared with that in patients with GVHD (p < 0.01). However, no such difference was observed between SJS/TEN and EM. These findings suggest that an MPO/CD3 > 1 is a pathologic feature of SJS/TEN; however, its specificity may be limited.
Indexed as
Identifiers
41057663What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.